𝔖 Bobbio Scriptorium
✦   LIBER   ✦

E1A – oncogene or tumor suppressor?

✍ Scribed by Steven M. Frisch


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
145 KB
Volume
17
Category
Article
ISSN
0265-9247

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


The paradox of E2F1: Oncogene and tumor
✍ David G. Johnson 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

Cancer cells often contain mutations that lead to the loss of retinoblastoma tumor suppressor (Rb) function and the activation of E2F-dependent transcription. As a result, proliferation is deregulated, and sensitivity to apoptotic stimuli is increased. In cell culture studies, the transcription fact

E-cadherin as a tumor (invasion) suppres
✍ Walter Birchmeier 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 1 views

Diffuse-type gastric carcinomas show diminished cell-cell adhesion. A recent paper(') reports that 50% of these carcinomas contain mutations in the Ecadherin gene, resulting in the destruction of the calcium-binding sites of Ecadherin, and providing strong in vivo evidence that alterations in E-cadh

Analysis of oncogene, tumor suppressor g
✍ Robert J. Isfort; David B. Cody; Glenda J. Lovell; Daniel Gioeli; Bernard E. Wei 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB 👁 2 views

Using a series of tumorigenic and non-tumorigenic somatic cell hybrids that resulted from the fusion of the human osteosarcoma cell line OHS50-P16T (P16T) with the HeLa cell line D98OR, we investigated the role that genetic mutations, including alterations of oncogenes, tumor suppressor genes, and c

A tumor suppressor locus in familial and
✍ Monica Miozzo; Leda Dalprà; Paola Riva; Marinella Volontà; Fabio Macciardi; Serg 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 150 KB 👁 1 views

Previous cytogenetic/FISH data have demonstrated 1p36 deletions in a relapsing familial clivus chordoma developed by a patient who has 2 daughters, respectively affected with childhood astrocytoma and clivus chordoma. Using an approach that combined the LOH (loss of heterozygosity) study of the fath

Codeletion of the JUN proto-oncogene and
✍ Jian-Nian Zhou; Sofia Ljungdahl; Dan Röhme; Göran Levan; Maria C. Shoshan; Stig 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 2 views

The cyclin kinase inhibitor p16, encoded by the CDKN2A gene, suppresses the transformation of mouse embryonic fibroblasts by oncogenic RAS. In contrast, the c-JUN transcription factor (a major component of AP-1) has been suggested to be required for RAS transformation of rodent fibroblasts. The CDKN